{"id":5521,"date":"2023-06-05T18:55:56","date_gmt":"2023-06-05T18:55:56","guid":{"rendered":"https:\/\/organonpro.com\/en-us\/?post_type=product&#038;p=5521"},"modified":"2026-02-03T17:12:55","modified_gmt":"2026-02-03T17:12:55","slug":"pediatric-dosing","status":"publish","type":"product","link":"https:\/\/organonpro.com\/en-us\/product\/hadlima\/dosing-administration\/pediatric-dosing\/","title":{"rendered":"Dosing Schedule for Pediatrics"},"content":{"rendered":"\n<h2 class=\"wp-block-heading has-text-color\" id=\"h-dosing-schedule-for-pediatric-indications\" style=\"color:#19105f\">Dosing schedule for pediatric indications<\/h2>\n\n\n\n<p><strong>Prior to initiating HADLIMA and periodically during therapy, evaluate patients for active tuberculosis and test for latent infection.<\/strong><\/p>\n\n\n\n<div class=\"wp-block-aab-accordion-block aab__accordion_container separate-accordion  no-pro-plan\"><div><div class=\"aab__accordion_head aab_right_icon  \" data-active=\"false\" style=\"color:;background-color:\"><div class=\"aab__accordion_heading aab_right_icon aab_right_link\"><h3 class=\"aab__accordion_title\" style=\"margin:0;color:\" itemprop=\"name\">For pediatric patients (by weight): moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in children 2 years of age and older<\/h3><\/div><div class=\"aab__accordion_icon\" style=\"color:;background-color:\"><span class=\"aab__icon dashicons dashicons-arrow-down-alt2\" style=\"font-size:25px\"><\/span><\/div><\/div><div class=\"aab__accordion_body \" role=\"region\" style=\"background-color:\"><div itemprop=\"text\">\n<p>The recommended subcutaneous dosage of HADLIMA for patients 2 years of age and older with polyarticular JIA is based on weight as shown below.<\/p>\n\n\n\n<p class=\"has-text-color has-link-color wp-elements-9209ad164f6456f0e9593ee1b310ad38\" style=\"color:#cd336a\"><strong>Patient\u2019s weight: 66 lb (30 kg) and greater<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>40 mg subcutaneously every other week<\/strong><\/li>\n<\/ul>\n\n\n\n<p>Note: There is no dosage form available for HADLIMA that allows weight-based dosing for pediatric patients below 66 lb (30 kg).<\/p>\n\n\n\n<p>Adalimumab products have not been studied in patients with polyarticular JIA less than 2 years of age or in patients with a weight below 22 lb (10 kg).<\/p>\n\n\n\n<p>MTX, glucocorticoids, NSAIDs, and\/or analgesics may be continued during treatment with HADLIMA.<\/p>\n<\/div><\/div><\/div><\/div>\n\n\n\n<div class=\"wp-block-aab-accordion-block aab__accordion_container separate-accordion  no-pro-plan\"><div><div class=\"aab__accordion_head aab_right_icon  \" data-active=\"false\" style=\"color:;background-color:\"><div class=\"aab__accordion_heading aab_right_icon aab_right_link\"><h3 class=\"aab__accordion_title\" style=\"margin:0;color:\" itemprop=\"name\">For pediatric patients (by weight): moderately to severely active Crohn\u2019s disease (CD) in children 6 years of age and older<\/h3><\/div><div class=\"aab__accordion_icon\" style=\"color:;background-color:\"><span class=\"aab__icon dashicons dashicons-arrow-down-alt2\" style=\"font-size:25px\"><\/span><\/div><\/div><div class=\"aab__accordion_body \" role=\"region\" style=\"background-color:\"><div itemprop=\"text\">\n<p>The recommended subcutaneous dosage of HADLIMA for pediatric patients 6 years of age and older with CD is based on body weight as shown below.<\/p>\n\n\n\n<p class=\"has-text-color has-link-color wp-elements-4fd9bee902c05bd4b5078a874aafd072\" style=\"color:#cd336a\"><strong>Patient\u2019s weight: 88 lb (40 kg) and greater<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Day 1: 160 mg subcutaneously (single dose or split over 2 consecutive days)<\/strong><\/li>\n\n\n\n<li><strong>Day 15: 80 mg subcutaneously<\/strong><\/li>\n\n\n\n<li><strong>Day 29: 40 mg subcutaneously every other week<\/strong><\/li>\n<\/ul>\n\n\n\n<p>Note: There is no dosage form available for HADLIMA that allows weight-based dosing for pediatric patients below 88 lb (40 kg).<\/p>\n<\/div><\/div><\/div><\/div>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-small-font-size\">MTX, methotrexate; NSAIDs, nonsteroidal anti-inflammatory drugs.<\/p>\n","protected":false},"author":72,"featured_media":0,"parent":5515,"menu_order":4,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"tags":[],"product_categories":[],"product_specialization":[],"customer_type":[],"class_list":["post-5521","product","type-product","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.11 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pediatric Dosing Schedule for HADLIMA\u2122 (adalimumab-bwwd)<\/title>\n<meta name=\"description\" content=\"Review the pediatric dosing schedule for HADLIMA\u2122 (adalimumab-bwwd), including the recommended subcutaneous dosage of HADLIMA for pediatric patients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/organonpro.com\/en-us\/product\/hadlima\/dosing-administration\/pediatric-dosing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dosing Schedule for Pediatrics\" \/>\n<meta property=\"og:description\" content=\"Review the pediatric dosing schedule for HADLIMA\u2122 (adalimumab-bwwd), including the recommended subcutaneous dosage of HADLIMA for pediatric patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/organonpro.com\/en-us\/product\/hadlima\/dosing-administration\/pediatric-dosing\/\" \/>\n<meta property=\"og:site_name\" content=\"US\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-03T17:12:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/organonpro.com\/en-us\/wp-content\/uploads\/sites\/6\/2022\/12\/organon-pro-og-img.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pediatric Dosing Schedule for HADLIMA\u2122 (adalimumab-bwwd)","description":"Review the pediatric dosing schedule for HADLIMA\u2122 (adalimumab-bwwd), including the recommended subcutaneous dosage of HADLIMA for pediatric patients.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/organonpro.com\/en-us\/product\/hadlima\/dosing-administration\/pediatric-dosing\/","og_locale":"en_US","og_type":"article","og_title":"Dosing Schedule for Pediatrics","og_description":"Review the pediatric dosing schedule for HADLIMA\u2122 (adalimumab-bwwd), including the recommended subcutaneous dosage of HADLIMA for pediatric patients.","og_url":"https:\/\/organonpro.com\/en-us\/product\/hadlima\/dosing-administration\/pediatric-dosing\/","og_site_name":"US","article_modified_time":"2026-02-03T17:12:55+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/organonpro.com\/en-us\/wp-content\/uploads\/sites\/6\/2022\/12\/organon-pro-og-img.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/organonpro.com\/en-us\/product\/hadlima\/dosing-administration\/pediatric-dosing\/","url":"https:\/\/organonpro.com\/en-us\/product\/hadlima\/dosing-administration\/pediatric-dosing\/","name":"Pediatric Dosing Schedule for HADLIMA\u2122 (adalimumab-bwwd)","isPartOf":{"@id":"https:\/\/organonpro.com\/en-us\/#website"},"datePublished":"2023-06-05T18:55:56+00:00","dateModified":"2026-02-03T17:12:55+00:00","description":"Review the pediatric dosing schedule for HADLIMA\u2122 (adalimumab-bwwd), including the recommended subcutaneous dosage of HADLIMA for pediatric patients.","breadcrumb":{"@id":"https:\/\/organonpro.com\/en-us\/product\/hadlima\/dosing-administration\/pediatric-dosing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/organonpro.com\/en-us\/product\/hadlima\/dosing-administration\/pediatric-dosing\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/organonpro.com\/en-us\/product\/hadlima\/dosing-administration\/pediatric-dosing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/organonpro.com\/en-us\/"},{"@type":"ListItem","position":2,"name":"Products","item":"https:\/\/organonpro.com\/en-us\/product\/"},{"@type":"ListItem","position":3,"name":"HADLIMA\u2122","item":"https:\/\/organonpro.com\/en-us\/product\/hadlima\/"},{"@type":"ListItem","position":4,"name":"Dosing &amp; Administration","item":"https:\/\/organonpro.com\/en-us\/product\/hadlima\/dosing-administration\/"},{"@type":"ListItem","position":5,"name":"Dosing Schedule for Pediatrics"}]},{"@type":"WebSite","@id":"https:\/\/organonpro.com\/en-us\/#website","url":"https:\/\/organonpro.com\/en-us\/","name":"US","description":"Here for her health","publisher":{"@id":"https:\/\/organonpro.com\/en-us\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/organonpro.com\/en-us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/organonpro.com\/en-us\/#organization","name":"Organon Pro","url":"https:\/\/organonpro.com\/en-us\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/organonpro.com\/en-us\/#\/schema\/logo\/image\/","url":"https:\/\/organonpro.com\/en-us\/wp-content\/uploads\/sites\/6\/2022\/08\/ORGANON_PRO_1Color_Logo_White_RGB_M01.png","contentUrl":"https:\/\/organonpro.com\/en-us\/wp-content\/uploads\/sites\/6\/2022\/08\/ORGANON_PRO_1Color_Logo_White_RGB_M01.png","width":2579,"height":529,"caption":"Organon Pro"},"image":{"@id":"https:\/\/organonpro.com\/en-us\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.instagram.com\/hereforherhealth\/","https:\/\/www.linkedin.com\/company\/organon"]}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/organonpro.com\/en-us\/wp-json\/wp\/v2\/product\/5521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/organonpro.com\/en-us\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/organonpro.com\/en-us\/wp-json\/wp\/v2\/types\/product"}],"author":[{"embeddable":true,"href":"https:\/\/organonpro.com\/en-us\/wp-json\/wp\/v2\/users\/72"}],"replies":[{"embeddable":true,"href":"https:\/\/organonpro.com\/en-us\/wp-json\/wp\/v2\/comments?post=5521"}],"version-history":[{"count":7,"href":"https:\/\/organonpro.com\/en-us\/wp-json\/wp\/v2\/product\/5521\/revisions"}],"predecessor-version":[{"id":10766,"href":"https:\/\/organonpro.com\/en-us\/wp-json\/wp\/v2\/product\/5521\/revisions\/10766"}],"up":[{"embeddable":true,"href":"https:\/\/organonpro.com\/en-us\/wp-json\/wp\/v2\/product\/5515"}],"wp:attachment":[{"href":"https:\/\/organonpro.com\/en-us\/wp-json\/wp\/v2\/media?parent=5521"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/organonpro.com\/en-us\/wp-json\/wp\/v2\/tags?post=5521"},{"taxonomy":"product_categories","embeddable":true,"href":"https:\/\/organonpro.com\/en-us\/wp-json\/wp\/v2\/product_categories?post=5521"},{"taxonomy":"product_specialization","embeddable":true,"href":"https:\/\/organonpro.com\/en-us\/wp-json\/wp\/v2\/product_specialization?post=5521"},{"taxonomy":"customer_type","embeddable":true,"href":"https:\/\/organonpro.com\/en-us\/wp-json\/wp\/v2\/customer_type?post=5521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}